Commentaries
Imiquimoid 5%: In Pursuit of New Treatment Regimens for Actinic Keratosis
Búsqueda de nuevas pautas terapéuticas de imiquimod 5% para el tratamiento de las queratosis actínicas
R. Salido Vallejo
Servicio de Dermatología, Hospital Reina Sofía, Córdoba, España
Leído
4738
Vecesse ha leído el artículo
1820
Total PDF
2918
Total HTML
Compartir estadísticas
array:24 [ "pii" => "S1578219018300209" "issn" => "15782190" "doi" => "10.1016/j.adengl.2018.02.018" "estado" => "S300" "fechaPublicacion" => "2018-04-01" "aid" => "1857" "copyright" => "Elsevier España, S.L.U. and AEDV" "copyrightAnyo" => "2017" "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "cor" "cita" => "Actas Dermosifiliogr. 2018;109:200" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 65 "formatos" => array:2 [ "HTML" => 63 "PDF" => 2 ] ] "Traduccion" => array:1 [ "es" => array:19 [ "pii" => "S0001731017306282" "issn" => "00017310" "doi" => "10.1016/j.ad.2017.11.005" "estado" => "S300" "fechaPublicacion" => "2018-04-01" "aid" => "1857" "copyright" => "AEDV" "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "cor" "cita" => "Actas Dermosifiliogr. 2018;109:200" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 180 "formatos" => array:2 [ "HTML" => 122 "PDF" => 58 ] ] "es" => array:10 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Comentarios Editoriales</span>" "titulo" => "Búsqueda de nuevas pautas terapéuticas de imiquimod 5% para el tratamiento de las queratosis actínicas" "tienePdf" => "es" "tieneTextoCompleto" => "es" "paginas" => array:1 [ 0 => array:1 [ "paginaInicial" => "200" ] ] "titulosAlternativos" => array:1 [ "en" => array:1 [ "titulo" => "Imiquimoid 5%: In Pursuit of New Treatment Regimens for Actinic Keratosis" ] ] "contieneTextoCompleto" => array:1 [ "es" => true ] "contienePdf" => array:1 [ "es" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "R. Salido Vallejo" "autores" => array:1 [ 0 => array:2 [ "nombre" => "R." "apellidos" => "Salido Vallejo" ] ] ] ] ] "idiomaDefecto" => "es" "Traduccion" => array:1 [ "en" => array:9 [ "pii" => "S1578219018300209" "doi" => "10.1016/j.adengl.2018.02.018" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1578219018300209?idApp=UINPBA000044" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0001731017306282?idApp=UINPBA000044" "url" => "/00017310/0000010900000003/v1_201804020403/S0001731017306282/v1_201804020403/es/main.assets" ] ] "itemSiguiente" => array:19 [ "pii" => "S1578219018300398" "issn" => "15782190" "doi" => "10.1016/j.adengl.2018.02.022" "estado" => "S300" "fechaPublicacion" => "2018-04-01" "aid" => "1878" "copyright" => "Elsevier España, S.L.U. and AEDV" "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "cor" "cita" => "Actas Dermosifiliogr. 2018;109:200-1" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 63 "formatos" => array:2 [ "HTML" => 62 "PDF" => 1 ] ] "en" => array:10 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Commentaries</span>" "titulo" => "Imatinib: A New Tool for the Management of Chronic Sclerodermatous Graft-vs-Host Disease" "tienePdf" => "en" "tieneTextoCompleto" => "en" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "200" "paginaFinal" => "201" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Imatinib: Una nueva herramienta para el manejo de la enfermedad del injerto contra el hospedador crónica esclerodermiforme" ] ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "C. Ferrándiz-Pulido" "autores" => array:1 [ 0 => array:2 [ "nombre" => "C." "apellidos" => "Ferrándiz-Pulido" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "es" => array:9 [ "pii" => "S0001731017306750" "doi" => "10.1016/j.ad.2017.12.002" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0001731017306750?idApp=UINPBA000044" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1578219018300398?idApp=UINPBA000044" "url" => "/15782190/0000010900000003/v1_201804020430/S1578219018300398/v1_201804020430/en/main.assets" ] "itemAnterior" => array:19 [ "pii" => "S157821901830009X" "issn" => "15782190" "doi" => "10.1016/j.adengl.2018.02.007" "estado" => "S300" "fechaPublicacion" => "2018-04-01" "aid" => "1737" "copyright" => "Elsevier España, S.L.U. and AEDV" "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "cor" "cita" => "Actas Dermosifiliogr. 2018;109:199" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 68 "formatos" => array:3 [ "EPUB" => 1 "HTML" => 64 "PDF" => 3 ] ] "en" => array:10 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Commentary</span>" "titulo" => "Broadening the Sonographic Spectrum of Vascular Anomalies" "tienePdf" => "en" "tieneTextoCompleto" => "en" "paginas" => array:1 [ 0 => array:1 [ "paginaInicial" => "199" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Ampliando el espectro ecográfico de las anomalías vasculares" ] ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "F. Alfageme" "autores" => array:1 [ 0 => array:2 [ "nombre" => "F." "apellidos" => "Alfageme" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "es" => array:9 [ "pii" => "S0001731017303472" "doi" => "10.1016/j.ad.2017.06.005" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0001731017303472?idApp=UINPBA000044" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S157821901830009X?idApp=UINPBA000044" "url" => "/15782190/0000010900000003/v1_201804020430/S157821901830009X/v1_201804020430/en/main.assets" ] "en" => array:12 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Commentaries</span>" "titulo" => "Imiquimoid 5%: In Pursuit of New Treatment Regimens for Actinic Keratosis" "tieneTextoCompleto" => true "paginas" => array:1 [ 0 => array:1 [ "paginaInicial" => "200" ] ] "autores" => array:1 [ 0 => array:3 [ "autoresLista" => "R. Salido Vallejo" "autores" => array:1 [ 0 => array:3 [ "nombre" => "R." "apellidos" => "Salido Vallejo" "email" => array:1 [ 0 => "rsalidovallejo@gmail.com" ] ] ] "afiliaciones" => array:1 [ 0 => array:2 [ "entidad" => "Servicio de Dermatología, Hospital Reina Sofía, Córdoba, España" "identificador" => "aff0005" ] ] ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Búsqueda de nuevas pautas terapéuticas de imiquimod 5% para el tratamiento de las queratosis actínicas" ] ] "textoCompleto" => "<span class="elsevierStyleSections"><p id="par0005" class="elsevierStylePara elsevierViewall">Actinic keratoses are intraepidermal skin tumors that appear in the context of a type of chronic actinic damage known as field cancerization. New treatments tend to cover not only clinically visible lesions, but also those that harbor subclinical dysplastic changes. Therefore, classic drugs such as imiquimod have returned to the fore because of their formulation, which is available in various concentrations,<a class="elsevierStyleCrossRef" href="#bib0015"><span class="elsevierStyleSup">1</span></a> and the search for an optimal regimen that enables us to adapt the inflammatory reaction as much as possible to the clinical response.</p><p id="par0010" class="elsevierStylePara elsevierViewall">In this article, Serra-Guillén et al.<a class="elsevierStyleCrossRef" href="#bib0020"><span class="elsevierStyleSup">2</span></a> investigate a new regimen of imiquimod 5% cream for the treatment of actinic keratosis. The authors propose a concentrated regimen in which they apply the drug daily for 12 consecutive days with the aim of finding a better response to therapy and a shorter duration of local cutaneous responses. The data obtained show the regimen to be slightly more effective than that reported in the summary of product characteristics, albeit at the cost of poorer tolerance. Furthermore, the linear correlation between the severity of the local reactions and the degree of clinical response can help us to predict the response to imiquimod, which is sometimes quite erratic, depending on the patient. In this interesting article, our colleagues from Instituto Valenciano de Oncología use high-quality data to reinforce the trend observed in daily clinical practice and the philosophy of “no pain, no gain”, which we try to transmit to patients so that a correct understanding of the mechanism of action of this drug leads to appropriate adherence and, therefore, a successful outcome.</p></span>" "pdfFichero" => "main.pdf" "tienePdf" => true "NotaPie" => array:1 [ 0 => array:2 [ "etiqueta" => "☆" "nota" => "<p class="elsevierStyleNotepara" id="npar0005">Please cite this article as: Salido Vallejo R. Búsqueda de nuevas pautas terapéuticas de imiquimod 5% para el tratamiento de las queratosis actínicas. Actas Dermosifiliogr. 2018;109:200.</p>" ] ] "bibliografia" => array:2 [ "titulo" => "References" "seccion" => array:1 [ 0 => array:2 [ "identificador" => "bibs0015" "bibliografiaReferencia" => array:2 [ 0 => array:3 [ "identificador" => "bib0015" "etiqueta" => "1" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Imiquimod 3.75% in actinic keratosis: Efficacy in patients with and without rest periods during treatment" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "T. Dirschka" 1 => "K. Peris" 2 => "G. Gupta" 3 => "A. Alomar" 4 => "S. Aractingi" 5 => "R. Dakovic" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1111/jdv.13260" "Revista" => array:6 [ "tituloSerie" => "J Eur Acad Dermatol Venereol" "fecha" => "2016" "volumen" => "30" "paginaInicial" => "1416" "paginaFinal" => "1417" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/26303677" "web" => "Medline" ] ] ] ] ] ] ] ] 1 => array:3 [ "identificador" => "bib0020" "etiqueta" => "2" "referencia" => array:1 [ 0 => array:1 [ "referenciaCompleta" => "Serra-Guillén C, Nagore E, Llombart B, Sanmartin O, Requena C, Calomarde L, et al. Tratamiento con Imiquimod al 5% durante 12 días para las queratosis actínicas: estudio de la eficacia y la reacción local. Actas Dermosifiliogr. 2017" ] ] ] ] ] ] ] ] "idiomaDefecto" => "en" "url" => "/15782190/0000010900000003/v1_201804020430/S1578219018300209/v1_201804020430/en/main.assets" "Apartado" => array:4 [ "identificador" => "66476" "tipo" => "SECCION" "en" => array:2 [ "titulo" => "Commentaries" "idiomaDefecto" => true ] "idiomaDefecto" => "en" ] "PDF" => "https://static.elsevier.es/multimedia/15782190/0000010900000003/v1_201804020430/S1578219018300209/v1_201804020430/en/main.pdf?idApp=UINPBA000044&text.app=https://actasdermo.org/" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1578219018300209?idApp=UINPBA000044" ]
| año/Mes | Html | Total | |
|---|---|---|---|
| 2024 Noviembre | 9 | 7 | 16 |
| 2024 Octubre | 85 | 37 | 122 |
| 2024 Septiembre | 69 | 26 | 95 |
| 2024 Agosto | 102 | 56 | 158 |
| 2024 Julio | 79 | 32 | 111 |
| 2024 Junio | 78 | 26 | 104 |
| 2024 Mayo | 64 | 31 | 95 |
| 2024 Abril | 62 | 30 | 92 |
| 2024 Marzo | 82 | 25 | 107 |
| 2024 Febrero | 67 | 31 | 98 |
| 2024 Enero | 69 | 36 | 105 |
| 2023 Diciembre | 69 | 13 | 82 |
| 2023 Noviembre | 76 | 27 | 103 |
| 2023 Octubre | 60 | 19 | 79 |
| 2023 Septiembre | 67 | 29 | 96 |
| 2023 Agosto | 45 | 14 | 59 |
| 2023 Julio | 52 | 30 | 82 |
| 2023 Junio | 53 | 27 | 80 |
| 2023 Mayo | 61 | 27 | 88 |
| 2023 Abril | 62 | 17 | 79 |
| 2023 Marzo | 67 | 28 | 95 |
| 2023 Febrero | 60 | 28 | 88 |
| 2023 Enero | 46 | 28 | 74 |
| 2022 Diciembre | 51 | 42 | 93 |
| 2022 Noviembre | 28 | 34 | 62 |
| 2022 Octubre | 33 | 20 | 53 |
| 2022 Septiembre | 19 | 36 | 55 |
| 2022 Agosto | 31 | 37 | 68 |
| 2022 Julio | 23 | 33 | 56 |
| 2022 Junio | 22 | 30 | 52 |
| 2022 Mayo | 49 | 33 | 82 |
| 2022 Abril | 53 | 43 | 96 |
| 2022 Marzo | 48 | 63 | 111 |
| 2022 Febrero | 31 | 32 | 63 |
| 2022 Enero | 51 | 38 | 89 |
| 2021 Diciembre | 36 | 49 | 85 |
| 2021 Noviembre | 53 | 50 | 103 |
| 2021 Octubre | 52 | 53 | 105 |
| 2021 Septiembre | 29 | 36 | 65 |
| 2021 Agosto | 38 | 45 | 83 |
| 2021 Julio | 37 | 38 | 75 |
| 2021 Junio | 33 | 32 | 65 |
| 2021 Mayo | 46 | 43 | 89 |
| 2021 Abril | 71 | 76 | 147 |
| 2021 Marzo | 96 | 32 | 128 |
| 2021 Febrero | 74 | 33 | 107 |
| 2021 Enero | 45 | 45 | 90 |
| 2020 Diciembre | 52 | 41 | 93 |
| 2020 Noviembre | 54 | 32 | 86 |
| 2020 Octubre | 25 | 15 | 40 |
| 2020 Septiembre | 27 | 17 | 44 |
| 2020 Agosto | 39 | 27 | 66 |
| 2020 Julio | 26 | 20 | 46 |
| 2020 Junio | 39 | 30 | 69 |
| 2020 Mayo | 11 | 9 | 20 |
| 2020 Abril | 22 | 14 | 36 |
| 2020 Marzo | 24 | 16 | 40 |
| 2020 Febrero | 4 | 0 | 4 |
| 2020 Enero | 3 | 0 | 3 |
| 2019 Diciembre | 8 | 0 | 8 |
| 2019 Noviembre | 6 | 0 | 6 |
| 2019 Septiembre | 10 | 0 | 10 |
| 2019 Agosto | 3 | 0 | 3 |
| 2019 Julio | 7 | 2 | 9 |
| 2019 Junio | 4 | 0 | 4 |
| 2019 Mayo | 6 | 0 | 6 |
| 2019 Abril | 2 | 0 | 2 |
| 2019 Marzo | 2 | 0 | 2 |
| 2019 Febrero | 2 | 0 | 2 |
| 2018 Diciembre | 2 | 0 | 2 |
| 2018 Noviembre | 2 | 0 | 2 |
| 2018 Octubre | 1 | 0 | 1 |
| 2018 Septiembre | 2 | 0 | 2 |
| 2018 Abril | 2 | 0 | 2 |
Mostrar todo
